Clinical Trial: Phase IIb Trial to Investigate the Safety and Efficacy of OTL78 Injection (Zopocianine)

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07725523) titled 'Phase IIb Trial to Investigate the Safety and Efficacy of OTL78 Injection (Zopocianine)' on July 21.

Brief Summary: This study is being done to support the selection of single dose and timing regimen of Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging to improve the detection of malignant (growing in an uncontrolled way) tissue in adult patients undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Prostate Cancer Surgery Prostate Cancer Metastatic Disease

Intervention: DRUG: 0.06mg/kg ZOPOCIANI...